Seeking nominations of individuals to serve on a panel to develop a clinical practice guideline for treatment and management of chronic musculoskeletal pain in adults.

APA’s Advisory Steering Committee for the Development of Clinical Practice Guidelines is seeking nominations of individuals to serve on a panel to develop a clinical practice guideline for treatment and management of chronic musculoskeletal pain in adults. The guideline will address psychosocial, behavioral, exercise, pharmacological and combined approaches to treating and managing pain, with an emphasis on delivery of treatment within integrated care models.

Individuals are asked to self-nominate. Nominees who will enhance the diversity of the development panels are particularly encouraged to apply.

The development panel will be composed of at least seven members. Members may serve on only one active APA guideline development panel at a time although they may serve on more than one over the course of time. The development panel will include psychologists as well as individuals from other disciplines (such as neuroscience, pharmacology, medicine, physical therapy, nursing, social work, etc.). The advisory steering committee will select a chair from among the members of the development panel. It is expected that the panel will take approximately two to three years to complete its work.

The development panel will consist of at least:

  • Three content experts in chronic musculoskeletal pain.
  • One full-time generalist practitioner.
  • One patient/consumer/community member/advocate.
  • One biostatistician or methodologist.

Among the content experts, a breadth of perspectives will be represented and will include both experts who are primarily researchers and those who are primarily practitioners. Task force members should have knowledge of treatment issues related to age and other dimensions of diversity (such as race/ethnicity, socioeconomic status, culture, gender, sexuality, physical and mental abilities). It is anticipated that task force members will collectively have experience working with a broad range of populations and in a broad range of settings. Membership in APA is not a requirement to serve on the panel.

Background or expertise in one or more of the following areas may be useful to the panel:

  • Chronic pain, including musculoskeletal pain.
  • Clinical practice guideline development.
  • Comparative effectiveness research.
  • Systematic reviews.
  • Design and conduct of clinical trials.
  • Contemporary methods for evaluation of psychological, behavioral, or pharmacological interventions.
  • Dissemination/implementation research.
  • Relevant expertise in research design and statistical analysis.
  • Experience applying clinical practice guidelines in practice settings.
  • Experience using or providing training in evidence-based practices.
  • Direct provision of psychological or medical care in diverse practice settings or with diverse populations.
  • Patient/consumer perspective.
  • Federal agency policies and programs related to guidelines.
  • Health care systems finance or administration.
  • Public health research and applications.
  • Public and community health delivery systems.

The development panel will determine the specific scope and focus of the guideline for the treatment of chronic musculoskeletal pain. It will write the guideline document based on systematic reviews of the research literature. The panel will not conduct the systematic reviews itself but will develop the questions that will determine which existing systematic reviews are used or new systematic reviews are solicited, in collaboration with the advisory steering committee and potentially other consultants.

The guideline will include treatment recommendations and indications of the strength of the evidence for each recommendation in accordance with procedures developed by the advisory steering committee and consistent with current best practices in clinical practice guideline development.  Panel members will receive training and guidance concerning guideline development and systematic reviews from APA staff and the advisory steering committee.

With assistance from APA staff, the panel will provide progress reports to the advisory steering committee and the APA Board of Directors and governance groups on a regular basis.

Development panel members will be expected to commit to the following:

  • Attend at least two face-to-face meetings each year at APA headquarters in Washington, D.C. (to be scheduled after panel is constituted).
  • Active participation in monthly telephone conference calls as well as email communications.
  • During some periods, commit several hours per week to assessing systematic reviews and related literature and writing sections of the guideline document.
  • Willingness to serve for two to three years (or until the guideline is complete).
  • Responsive to emails and requests for information from fellow panel members and APA staff throughout the guideline development process.

The advisory steering committee will review nominees’ materials and submit recommendations to the APA Board of Directors, which makes appointments to the development panel.

Interested individuals should nominate themselves. Nomination materials should include a letter indicating your willingness to serve for two to three years (or until the guideline is complete), a brief statement of your specific expertise and qualifications related to the criteria above and a current curriculum vitae.

Current members of the following APA governance groups that have oversight of APA guideline activities are not eligible to serve on the panel: Board of Directors, Board of Professional Affairs, and Board of Scientific Affairs.

Please email all nominations and supporting materials to the APA Clinical Practice Guidelines mailbox by 11:59 p.m. (ET) Feb. 1, 2019. In the event of questions or difficulties regarding email transmissions, please contact Program Manager for Clinical Practice Guidelines Jacob Marzalik, MA, at (202) 336-5872.

Note: Candidates not selected for this development panel may nominate themselves for future panels.